Retatrutide 20mg (1 vial)

Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist currently in Phase 3 clinical trials. Sold strictly for research purposes only. Not for human consumption. Each vial contains 20mg lyophilized powder. Requires bacteriostatic water for reconstitution sold separately. For research purposes only.